-- 
El Al, Delek, Dor Alon, Partner, Avgol: Israeli Equity Preview

-- B y   S h a r o n   W r o b e l
-- 
2011-05-25T06:39:33Z

-- http://www.bloomberg.com/news/2011-05-25/el-al-delek-dor-alon-partner-avgol-israeli-equity-preview.html
The following stocks may rise or fall
in Israeli markets. Stock symbols are in parentheses after
company names and prices are from the last close unless
otherwise stated.  The TA-25 Index lost 1 percent to 1,250.76 in  Tel Aviv .  Avgol Industries 1953 Ltd. (AVGL)  : The fabric
manufacturer said first-quarter net income increased to $6.9
million from $3.5 million a year earlier. Avgol dropped 0.6
percent to 2.55 shekels.  Bio Light Israeli Life Sciences Investments Ltd. (BOLT)  :
The I-Optima unit of the owner of companies that develop drugs
and medical technology received Israeli approval to market its
laser technology to treat Glaucoma. Bio Light dropped 4 percent
percent to 0.313 shekel.  Delek Group Ltd. (DLEKG)  :  Israel ’s Antitrust Authority
is considering declaring Isaac Tshuva’s holding company and
Noble Energy Inc. a monopoly in the natural-gas industry,
TheMarker reported, without saying where it obtained the
information. Delek retreated 2.6 percent to 813 shekels.
Antitrust Authority spokesperson Ilan Steiner said the regulator
is examining a number of possibilities.  Dor Alon Energy in Israel (1988) Ltd. (DRAL IT): The
operator of gas stations said first-quarter net income fell to
20.6 million shekels ($5.9 million) from 43.2 million shekels a
year earlier. Dor Alon declined 0.4 percent to 52.15 shekels.  El Al Israel Airlines (ELAL)  Ltd: The country’s
national carrier said first-quarter loss widened to $42.9
million from $16.5 million year earlier. El Al dropped 3.2
percent to 1.10 shekels.  Partner Communications Co. (PTNR IT): The country’s second-
largest mobile-phone operator is scheduled to report first-
quarter results. Partner gained 0.4 percent to 62.47 shekels.  To contact the reporter on this story:
Sharon Wrobel in Tel Aviv at 
 swrobel4@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  